TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23666832

Group type: EXPERIMENTAL
Intervention: Directly observed home-based daily iron therapy (DOHBIT)
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Unsupervised self-treatment at home
Number of subjects: 1059
Study: 23216534

Group type: EXPERIMENTAL
Intervention: Educational program for primary care physicians
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional care (reference group)
Number of subjects: 67
Study: 22010015

Group type: EXPERIMENTAL
Intervention: Dulanermin 8 mg/kg for 5 days with paclitaxel and carboplatin (arm 2)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Dulanermin 8 mg/kg for 5 days with paclitaxel, carboplatin, and bevacizumab (arm 4)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Dulanermin 20 mg/kg for 2 days with paclitaxel, carboplatin, and bevacizumab (arm 5)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Paclitaxel and carboplatin alone (arm 1)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Paclitaxel, carboplatin, and bevacizumab alone (arm 3)
Number of subjects: 213
Study: 18288936

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg once daily)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 433
Study: 16613190

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: X‐sizer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AngioJet
Number of subjects: 0
Study: 12844472

Group type: EXPERIMENTAL
Intervention: Vitamin-mineral drug combination containing dimethylaminoethanol (DMAE)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 9705050

Group type: COMPARATOR
Intervention: Thyroxine (T4) or tri‐iodothyronine (T3) or placebo
Number of subjects: 25
Study: 7890006

Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (Gab) infusion after liver resection
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 12
Study: 2778501

Group type: EXPERIMENTAL
Intervention: 800 mg daily oral sobrerol for 7 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 568917

Group type: EXPERIMENTAL
Intervention: Cow and Gate V formula
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Baby Milk Plus
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Premium
Number of subjects: 94

Group type: COMPARATOR
Intervention: Breastfed
Number of subjects: 94
Study: 31084488

Group type: EXPERIMENTAL
Intervention: Triamcinolone (40 mg) and lidocaine (1.5 mL) injection into the glenohumeral joint 8 weeks after surgery (group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline injection (group 2)
Number of subjects: 80
Study: 28218420

Group type: EXPERIMENTAL
Intervention: Aspirin and/or folic acid treatment
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 200
Study: 24949728

Group type: EXPERIMENTAL
Intervention: Advagraf
Number of subjects: 19

Group type: COMPARATOR
Intervention: Prograf
Number of subjects: 19
Study: 23078958

Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg per day)
Number of subjects: 670

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Erlotinib (with first-cycle rash)
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Erlotinib (without first-cycle rash)
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 670
Study: 19005755

Group type: EXPERIMENTAL
Intervention: Omeprazole, amoxicillin, metronidazole, and bismuth subcitrate (Group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Omeprazole, amoxicillin, and clarithromycin (Group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Omeprazole, amoxicillin‐clavulanic acid, and metronidazole (Group C)
Number of subjects: 120
Study: 17568284

Group type: EXPERIMENTAL
Intervention: Minimally invasive harvest (group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional technique (group C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Minimally invasive technique (group B)
Number of subjects: 100
Study: 15193939

Group type: EXPERIMENTAL
Intervention: Synchronisation tapping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuation tapping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initiate phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synchronise phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continue phase
Number of subjects: 0
Study: 12199276

Group type: EXPERIMENTAL
Intervention: Pilocarpine (15-30 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9815239

Group type: EXPERIMENTAL
Intervention: Stable nucleoside reverse transcriptase inhibitor therapy
Number of subjects: 387

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 387
Study: 7656926

Group type: EXPERIMENTAL
Intervention: Thyroid replacement therapy (TRT)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: L-thyroxine
Number of subjects: 372

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 372
Study: 2486951

Group type: EXPERIMENTAL
Intervention: Nimesulide 100 mg every 12 hrs for 5 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentiazac 100 mg every 12 hrs for 5 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mefenamic acid 500 mg every 8 hrs for 5 days
Number of subjects: 60
Study: 351570

Group type: EXPERIMENTAL
Intervention: Live instruction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Taped instruction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 60
Study: 31836203

Group type: EXPERIMENTAL
Intervention: Daily disposable soft contact lenses (Dailies Total 1, Dailies Aqua Comfort, TruEye, Biotrue Oneday)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No lens wear
Number of subjects: 32
Study: 31191639

Group type: EXPERIMENTAL
Intervention: Bidirectional modulation‐based SMR neurofeedback training (six-session protocol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging resting‐state sessions (before and after training)
Number of subjects: 0
Study: 28425239

Group type: EXPERIMENTAL
Intervention: 8-week thoracic spine stabilization exercise program
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 53
Study: 25542416

Group type: EXPERIMENTAL
Intervention: Low frequency pedaling rate (LFTr, 35 rpm)
Number of subjects: 16

Group type: COMPARATOR
Intervention: High frequency pedaling rate (HFTr, 75 rpm)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 35 rpm pedaling rate
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 75 rpm pedaling rate
Number of subjects: 16
Study: 23884017

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) of abdominal muscles during cough training for 6 weeks, 5 days per week (5 sets of 10 coughs per day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) of abdominal muscles
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cough training
Number of subjects: 15
Study: 21110014

Group type: EXPERIMENTAL
Intervention: Rabeprazole (RPZ) 10 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Rabeprazole (RPZ) 20 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Rabeprazole (RPZ) 40 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Rabeprazole (RPZ) high-dose
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Rabeprazole (RPZ) low-, middle-, and high-dose
Number of subjects: 63
Study: 19299273

Group type: EXPERIMENTAL
Intervention: Local anaesthesia (LA)
Number of subjects: 72

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 72
Study: 17143898

Group type: EXPERIMENTAL
Intervention: Proprioceptive training
Number of subjects: 64

Group type: COMPARATOR
Intervention: C‐CF training
Number of subjects: 64
Study: 17313003

Group type: EXPERIMENTAL
Intervention: Ankle-three-needle therapy
Number of subjects: 380

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 380

Group type: COMPARATOR
Intervention: Medication (aspirin-DL-lysine plus saline)
Number of subjects: 380
Study: 14564194

Group type: COMPARATOR
Intervention: Standard dose of dialysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: High dose of dialysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low flux dialyzer
Number of subjects: 0

Group type: COMPARATOR
Intervention: High flux dialyzer
Number of subjects: 0
Study: 10027500

Group type: EXPERIMENTAL
Intervention: Finger-temperature biofeedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow-release nifedipine (calcium channel blocker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonspecific behavioral control group
Number of subjects: 0
Study: 8933115

Group type: EXPERIMENTAL
Intervention: Flaked barley flapjack
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Barley flour flapjack
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flaked barley
Number of subjects: 12
Study: 1719730

Group type: EXPERIMENTAL
Intervention: Dextran 40
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% hydroxyethyl starch 200
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham-hemodilution
Number of subjects: 0
Study: 7015670

Group type: EXPERIMENTAL
Intervention: Cinoxacin
Number of subjects: 0
Study: 31377976

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 192
Study: 30260088

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27575450

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg sugammadex
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 2 mg/kg sugammadex
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 4 mg/kg sugammadex
Number of subjects: 180
Study: 26647750

Group type: EXPERIMENTAL
Intervention: Kinesio Taping
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Micropore (placebo)
Number of subjects: 60
Study: 23975857

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sulphasalazine
Number of subjects: 0
Study: 21106702

Group type: EXPERIMENTAL
Intervention: Progressive intensive treadmill training with virtual obstacles (TT + VR)
Number of subjects: 20
Study: 20158058

Group type: EXPERIMENTAL
Intervention: Home tray bleaching product
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: In surgery tray bleaching product
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: In surgery power bleaching product with light activation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: In surgery power bleaching product without light activation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo group (water)
Number of subjects: 50
Study: 17560166

Group type: EXPERIMENTAL
Intervention: Trivalent influenza vaccine
Number of subjects: 311

Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 311
Study: 15500306

Group type: EXPERIMENTAL
Intervention: Higher levels of therapist competence
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Therapists rated as more competent
Number of subjects: 49
Study: 11310462

Group type: EXPERIMENTAL
Intervention: Double Tubigrip bandage (DTG)
Number of subjects: 400

Group type: COMPARATOR
Intervention: No Double Tubigrip bandage
Number of subjects: 400
Study: 9152262

Group type: EXPERIMENTAL
Intervention: Training and consultation in continuous quality improvement and office prevention systems
Number of subjects: 6830

Group type: EXPERIMENTAL
Intervention: Favorable attitudes toward preventive services
Number of subjects: 6830

Group type: EXPERIMENTAL
Intervention: Factors related to the provision of preventive services
Number of subjects: 6830
Study: 7962892

Group type: EXPERIMENTAL
Intervention: Maritally focused stress interview
Number of subjects: 34

Group type: COMPARATOR
Intervention: Neutral talking control task
Number of subjects: 34
Study: 3307518

Group type: EXPERIMENTAL
Intervention: Ketorolac 1.5 mg/hour
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ketorolac 3.0 mg/hour
Number of subjects: 61

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 61
Study: 30827725

Group type: EXPERIMENTAL
Intervention: Anal cytology
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Anal HPV16/18 testing
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Overall prevalence of anal HSIL
Number of subjects: 75

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 75
Study: 29183347

Group type: EXPERIMENTAL
Intervention: Intensive smoking cessation intervention (motivational counselling combined with tailored nicotine replacement therapy)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 150
Study: 26483244

Group type: EXPERIMENTAL
Intervention: 20-29 pack-year current smokers
Number of subjects: 2283
Study: 23732949

Group type: EXPERIMENTAL
Intervention: Movement amplitude of 4° with ID 6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Movement amplitude of 8° and 16°
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High ID movements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4° amplitude
Number of subjects: 0
Study: 20649448

Group type: EXPERIMENTAL
Intervention: WM training in a gaming format
Number of subjects: 51

Group type: COMPARATOR
Intervention: Regular WM training (not in a gaming format)
Number of subjects: 51
Study: 19874084

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) for hemiplegic foot dorsiflexor muscles, 4 weeks, 5 days a week, total of 20 sessions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) combined with conventional rehabilitation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) and conventional rehabilitation
Number of subjects: 40
Study: 17105327

Group type: EXPERIMENTAL
Intervention: Presurgical orthopedic plate (IO+) until surgical closure of the soft palate at 52 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: No presurgical orthopedics (IO-)
Number of subjects: 54
Study: 14990633

Group type: EXPERIMENTAL
Intervention: Gefitinib 500 mg/d
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Gefitinib 250 mg/d
Number of subjects: 1037

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Gefitinib (500 mg/d and 250 mg/d)
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Gefitinib maintenance effect
Number of subjects: 1037
Study: 12019407

Group type: EXPERIMENTAL
Intervention: Enteral fluconazole
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 9595000

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normotensive subjects
Number of subjects: 20
Study: 7539182

Group type: EXPERIMENTAL
Intervention: Selective alpha 1 blockers
Number of subjects: 0
Study: 2485285

Group type: COMPARATOR
Intervention: Group C (money contingent on nonimpaired performance)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Group I (less valuable outcome - information only)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Group R (money scheduled randomly)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Group N (no outcome for performance)
Number of subjects: 24
Study: 336306

Group type: EXPERIMENTAL
Intervention: Fenoterol hydrobromide (0.1 mg, 0.2 mg, or 0.4 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isoproterenol (0.15 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Inert placebo propellant
Number of subjects: 20
Study: 30820962

Group type: EXPERIMENTAL
Intervention: Heparin-coated dialyzers
Number of subjects: 6

Group type: COMPARATOR
Intervention: Non-coated dialyzers
Number of subjects: 6
Study: 27326658

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 25768066

Group type: EXPERIMENTAL
Intervention: Stroke survivors with aspiration
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Stroke survivors without aspiration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 30
Study: 23838533

Group type: EXPERIMENTAL
Intervention: Web-based self-disclosure health support (WSHS) system
Number of subjects: 193

Group type: COMPARATOR
Intervention: Email health support (EHS)
Number of subjects: 193
Study: 22117299

Group type: EXPERIMENTAL
Intervention: Instructional condition encouraging grasping the topic of the text
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Instructional condition encouraging remembering details of the text
Number of subjects: 798

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 798
Study: 19815265

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg once daily with breakfast (de novo treatment)
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg once daily with breakfast (continuing treatment)
Number of subjects: 661

Group type: COMPARATOR
Intervention: Silodosin (de novo treatment)
Number of subjects: 661

Group type: COMPARATOR
Intervention: Silodosin (continuing treatment)
Number of subjects: 661
Study: 17610271

Group type: EXPERIMENTAL
Intervention: Tension-free Vaginal Tape (TVT)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Open Burch colposuspension (OBC)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Laparoscopic colposuspension with sutures (LCS)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Laparoscopic colposuspension with mesh and staples (LCM)
Number of subjects: 3
Study: 15472782

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10839062

Group type: EXPERIMENTAL
Intervention: Cognitive enhancement program 'Memories, Memories, Can We Improve Ours?' (8 sessions)
Number of subjects: 19
Study: 8930719

Group type: EXPERIMENTAL
Intervention: Neer's technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Modified technique (deltoid origin spared)
Number of subjects: 20
Study: 14621837

Group type: EXPERIMENTAL
Intervention: NON-HBD
Number of subjects: 34

Group type: COMPARATOR
Intervention: HBD
Number of subjects: 34
Study: 4083300

Group type: EXPERIMENTAL
Intervention: 24-hour sustained-release theophylline formulation, Uniphyl
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Twice-daily compound, Theo-Dur
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31158450

Group type: EXPERIMENTAL
Intervention: Single pivotal trials (20 randomized controlled trials and 15 single-arm trials)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Single pivotal trials
Number of subjects: 100
Study: 28799226

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of educational outreach visits with feedback on prescribing and the development of a working procedure on medication reviews (MRs). Follow-up duration was 9 months.
Number of subjects: 119910

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 119910

Group type: EXPERIMENTAL
Intervention: Educational intervention (same as above).
Number of subjects: 119910
Study: 25996838

Group type: EXPERIMENTAL
Intervention: HBvaxPRO® (10 μg)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Engerix B™
Number of subjects: 204
Study: 22819388

Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Central review of postimplantation CT scans
Number of subjects: 86
Study: 22303706

Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SFI) 1 mL/kg intravenously before induction of anesthesia and in priming solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 20
Study: 19575919

Group type: EXPERIMENTAL
Intervention: AcrySof IQ
Number of subjects: 260

Group type: COMPARATOR
Intervention: AcrySof Natural
Number of subjects: 260
Study: 16740846

Group type: EXPERIMENTAL
Intervention: Stimulant (dexamphetamine or methylphenidate)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Stimulant (post-trial management)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Stimulant (nonresponders)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Posttrial management
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: N-of-1 trials (overall management change)
Number of subjects: 108
Study: 15468546

Group type: EXPERIMENTAL
Intervention: Intraoperative hemodilution with colloids and crystalloids; donor packed red blood cells used at hemoglobin level below 80 g/l.
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Preparation of autoblood and hardware-based reinfusion of autoerythrocytes.
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Maintenance of hemoglobin below 90 g/l.
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group with autoblood preparation and limited infusion volume before aorta clipping.
Number of subjects: 116
Study: 11142483

Group type: EXPERIMENTAL
Intervention: IFN-chemotherapy induction treatment
Number of subjects: 3948

Group type: EXPERIMENTAL
Intervention: IFN maintenance therapy
Number of subjects: 3948

Group type: EXPERIMENTAL
Intervention: All IFN trials combined
Number of subjects: 3948

Group type: COMPARATOR
Intervention: Control (chemotherapy alone or without treatment)
Number of subjects: 3948
Study: 9294121

Group type: EXPERIMENTAL
Intervention: DNA-lipid complexes (GL-67:DOPE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: DNA alone (pCF1-CFTR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both DNA-lipid and DNA alone
Number of subjects: 0
Study: 8204943

Group type: EXPERIMENTAL
Intervention: Droloxifene 20 mg/day
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Droloxifene 40 mg/day
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Droloxifene 100 mg/day
Number of subjects: 369
Study: 3011530

Group type: EXPERIMENTAL
Intervention: LH-RH (25 micrograms as a single i.v. bolus)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride)
Number of subjects: 8